Replies to post #50567 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Keith, I agree with your comments that Dan was likely pushed out because of investor unrest regarding his lack of value creation and continuing cycle of dilution without any value-added deal making. With the exception of the Amgen deal, all other deals and collaborations he did were without a clear focus/strategy and weak financially. His only strength was his salesmanship in pitching investors to go in on his numerous dilutive offerings. His strength was also his weakness, because he lacked honesty or character and his efforts of tricking shareholders, putting his own financial interests ahead and using the annual proxy process as his own personal piggy bank finally caught up with him. I firmly believe the silence is leading up to a major BP deal or outright sale. Investors have already put their foot down regarding continuing the ongoing dilution cycle with no value added by giving Dan the boot. I'm optimistic the silence will end in a favorable outcome for investors. Otherwise, I'm sure Adage would have sold everything already if they got the impression shareholders will get diluted again on unfavorable terms.

[gold007_2000]

If that is true,Amgen is the only suspect,why in the world AMGEN put advaxis on the presentation on JPM conference, and you dont see that in all previous conference, strange, i think advaxis already in AMGEN pocket.

[abuhafsa]

That would be the dumbest thing any company would do.

Theres a reason why companies sign contracts: because it carries a legal obligation.. No company should put all those things on hold you mentioned because Amgen or whoever is talking sweet to them about an imminent deal. Only when the ink has dried is there a “deal”. Amgen could walk away any time before hat leaving Lombardo holding the bag. Thank goodness people like you don’t run companies.